EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis

Buying Li, Changjin Lu, Shijie Gao, Dandan Chen, Xue Heng, Kibret Mequanint iD, Malcolm Xing iD, Gaoxing Luo, Haisheng Li

Advanced Science · 2026-04 · 13 (23)

DOI: 10.1002/advs.202524002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.03.2026. Verfasst von Buying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing, China. Hauptthemen laut MEDLINE: Microbubbles, Macrophages, Receptors, CCR2, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing, Southwest Hospital Excellent Doctor Foundation, Luo Gaoxing Expert Workstation in Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical management of thrombosis, a primary cause of death worldwide, is hampered by the limitations of current thrombolytic agents, including short half‐life and high risk of off‐target bleeding. Here, we report the design and validation of an intelligent, inflammation‐targeting microbubble for precise thrombolysis. We first engineered macrophages to overexpress the C─C chemokine receptor 2 (CCR2) via lentiviral transfection. Membranes derived from these cells were then used to functionalize a liposomal structure, co‐encapsulating the thrombolytic drug urokinase (UK) and a phase‐change perfluoropropane gas. These resulting biomimetic microbubbles (termed UK@CCR2/MBs) were designed to navigate the vasculature and home in on thrombotic sites by binding to the highly expressed monocyte chemoattractant protein‐1 (MCP‐1) via the CCR2 receptor. Upon arrival at the target, localized low‐frequency ultrasound was applied to trigger acoustic droplet vaporization, leading to microbubble disruption and spatiotemporally controlled UK release. Extensive in vitro and in vivo evaluations, including in animal models of deep vein, carotid artery, and microcirculatory thrombosis, confirmed that UK@CCR2/MBs achieve superior thrombolytic efficacy and specific targeting with an excellent safety profile. This macrophage‐mimicking, ultrasound‐responsive system represents a sophisticated theranostic platform for the non‐invasive and targeted treatment of thrombotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobubblesMacrophagesReceptors, CCR2ThrombosisThrombolytic TherapyFibrinolytic AgentsAnimalsMiceDisease Models, AnimalHumans

Stichwörter der Autor:innen

Thrombosisinflammatory microenvironmentmacrophage membranemicrobubbleultrasound

Substanzen

Receptors, CCR2Fibrinolytic Agents

Autor:innen und Institutionen

  • Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing, China.
  • College of Bioengineering, Chongqing University, Chongqing, China.
  • Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON, Canada.
  • Department of Mechanical Engineering, University of Manitoba, Winnipeg, MB, Canada.

ORCID-Profile: Kibret Mequanint, Malcolm Xing

Förderung

  • Natural Science Foundation of Chongqing
  • Southwest Hospital Excellent Doctor Foundation
  • Luo Gaoxing Expert Workstation in Yunnan Province
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Li, B., Lu, C., Gao, S., Chen, D., Heng, X., Mequanint, K., Xing, M., Luo, G., & Li, H. (2026). Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis. Advanced Science, 13(23). https://doi.org/10.1002/advs.202524002

Vancouver

Li B, Lu C, Gao S, Chen D, Heng X, Mequanint K, et al. Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis. Advanced Science. 2026;13(23). doi:10.1002/advs.202524002

BibTeX
@article{Li2026,
  author = {Li, Buying and Lu, Changjin and Gao, Shijie and Chen, Dandan and Heng, Xue and Mequanint, Kibret and Xing, Malcolm and Luo, Gaoxing and Li, Haisheng},
  title = {Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {23},
  doi = {10.1002/advs.202524002}
}
Kostenlos starten →